Factors not considered in the study of drug‐resistant epilepsy: Drug‐resistant epilepsy: Assessment of neuroinflammation

Factors not considered in the study of drug‐resistant epilepsy: Drug‐resistant epilepsy: Assessment of neuroinflammation

Abstract More than one‐third of people with epilepsy develop drug‐resistant epilepsy (DRE). Different hypotheses have been proposed to explain the origin of DRE. Accumulating evidence suggests the contribution of neuroinflammation, modifications in the integrity of the blood‐brain barrier (BBB), and...

Full description

Bibliographic Details
Main Authors: Patricia Campos‐Bedolla, Iris Feria‐Romero, Sandra Orozco‐Suárez
Format: Article
Language:English
Published: Wiley 2022-08-01
Series:Epilepsia Open
Subjects:
blood‐brain barrier
cytokines
drug‐resistant epilepsy
neuroinflammation
polymorphisms
Online Access:https://doi.org/10.1002/epi4.12590

Similar Items

Similar Items